2024 Highlights
Also in this section
Cell and gene therapy approvals drive paradigm change in manufacturing
Will the tide turn for the wave of pharma layoffs?
AIDS 24: Prioritise at risk populations for trials, testing and treatment
Pharma readies for climate disasters amidst supply chain concerns
Amgen showcases exciting potential in the obesity space at JPM24
Experts call for a shift from reactive to proactive clinical trial supply frameworks